Potencies of Newer Fluoroquinolones against Viridans Group Streptococci Isolated in 637 Cases of Bloodstream Infection in the SENTRY Antimicrobial Surveillance Program (1997 to 1999): Beyond Canada!

R. Jones,M. Pfaller
DOI: https://doi.org/10.1128/AAC.44.10.2922-2923.2000
IF: 5.938
2000-10-01
Antimicrobial Agents and Chemotherapy
Abstract:de Azavedo and colleagues ([3][1]) reported that some newer fluoroquinolones possess activity against Canadian isolates of viridans group streptococci (VGS) that may have resistances to penicillins and macrolides. Since VGS organisms have been observed to be an important pathogen and cause of
What problem does this paper attempt to address?